China's medical insurance fund was in safe and effective operation in 2024, according to the latest report by the National Healthcare Security Administration on Monday. As of the end of last year, the ...
A new guideline from WHO conditionally recommends the use of GLP-1s to treat obesity as well as including the drugs as part of a comprehensive obesity treatment framework.